Analysed Vyne Therapeutics Inc (VYNE:NASDAQ) News Sources
VYNE Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
18-08-2025
yahoo.com
VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update
06-11-2025
yahoo.com
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
10-07-2026
yahoo.com
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
21-07-2026
yahoo.com
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience
23-07-2026
yahoo.com
Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease
27-07-2026
yahoo.com
What is the current price of Vyne Therapeutics Inc (VYNE:NASDAQ)?
The current price of Vyne Therapeutics Inc (VYNE:NASDAQ) is $35.02.
Vyne Therapeutics Inc (VYNE:NASDAQ) absolute price change since previous trading day?
The absolute price change of Vyne Therapeutics Inc (VYNE:NASDAQ) since the previous trading day is $2.03.
Vyne Therapeutics Inc (VYNE:NASDAQ) percentage price change since previous trading day?
The percentage price change of Vyne Therapeutics Inc (VYNE:NASDAQ) since the previous trading day is 6.1534%.
What is the most recent average sentiment score for Vyne Therapeutics Inc (VYNE:NASDAQ)?
The most recent average sentiment score for Vyne Therapeutics Inc (VYNE:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for Vyne Therapeutics Inc (VYNE:NASDAQ)?
The most recent sentiment for Vyne Therapeutics Inc (VYNE:NASDAQ) is .
SEC-8K** Filing Available For Vyne Therapeutics Inc (VYNE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.